艾滋病病毒阳性男男性行为者中新近获得性丙型肝炎病毒的自发性清除率低(PROBE-C研究)
PROBE-C观察性欧洲队列研究纳入2007至2017年464例HIV阳性MSM的新近获得性HCV感染,自发性清除率为11.9%(55/464)。诊断后4周HCV RNA下降>2 log是自发性清除的最强预测因素(P<.001;敏感性96.4%;特异性97.5%;阳性预测值84.1%;阴性预测值99.5%)。作者认为4周时HCV RNA下降<2 log应促使早期DAA治疗。
要点
- HIV阳性MSM中新近获得性HCV的自发性清除率仅11.9%(55/464)。
- 诊断后4周HCV RNA下降>2 log预测自发性清除:敏感性96.4%、特异性97.5%。
- 作者认为4周HCV RNA下降<2 log应促使早期DAA治疗。
核心结论
- HIV阳性MSM中新近获得性HCV的自发性清除仅见于11.9%的病例。
- 诊断后4周HCV RNA水平下降<2 log应促使早期DAA治疗。
- 对于持续存在传播风险行为的患者,也可能倾向于立即DAA治疗。
研究设计与样本
- PROBE-C研究是一项观察性欧洲队列,研究对象为HIV阳性MSM的新近获得性HCV感染。
- 2007年至2017年间记录新近获得性HCV感染,随访至少12个月。
- 共记录464例新近获得性HCV感染;464例中457例(98%)为男性,中位年龄(IQR)41(38-46)岁。
主要发现
- HCV传播的主要风险组为MSM(98.9%)。
- 大多数参与者感染HCV基因1型(78.3%)。
- 基线HCV RNA中位水平(IQR)为230 000(135 000-474 432)IU/mL,CD4+ T细胞计数中位值为574/µL(547-604/µL)。
- 92%的病例接受联合抗逆转录病毒治疗,91%显示HIV RNA水平受到抑制(<200 copies/mL)。
- 丙氨酸氨基转移酶中位最高水平(IQR)为445(402-522)U/L;自发性清除发生于464例中的55例(11.9%)。
关键数值与推荐
- 诊断后4周HCV RNA水平下降>2 log是自发性清除的最强预测因素(P<.001;敏感性96.4%;特异性97.5%;阳性预测值84.1%;阴性预测值99.5%)。
临床怎么用
- 作者认为诊断后4周HCV RNA水平下降<2 log应促使早期DAA治疗。
- 作者认为对于持续存在传播风险行为的患者,也可能倾向于立即DAA治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Using direct-acting antivirals (DAAs) for recently acquired hepatitis C virus (RAHCV) infections, particularly in human immunodeficiency virus (HIV)-positive men who have sex with men (MSM), dramatically reduced the incidence of hepatitis C. However, implementation into clinical practice is challenging. The aim of this study was to analyze spontaneous clearance (SC) rates of RAHCV and to identify predictors of SC. METHODS: The PROBE-C study is an observational European cohort on RAHCV infections in HIV-positive MSM. Between 2007 and 2017, RAHCV infections were documented with ≥12 months of follow-up. Fisher exact, χ2, and Mann-Whitney U tests were used for statistical analysis. RESULTS: A total of 464 RAHCV infections were documented; 457 of 464 patients (98%) were male, and the median age (interquartile range [IQR]) was 41 (38-46) years. The main risk group for hepatitis C virus (HCV) transmission was MSM (98.9%). Most participants were infected with HCV genotype 1 (78.3%). The median baseline HCV RNA level (IQR) was 230 000 (135 000-474 432) IU/mL, and the median CD4+ T-cell count was 574/µL (547-604/µL. Of all cases, 92% received combination antiretroviral therapy, with 91% showing suppressed HIV RNA levels (<200 copies/mL). The median maximum alanine aminotransferase level (IQR) was 445 (402-522) U/L. SC of RAHCV infection occurred in 55 of 464 cases (11.9%). A >2-log decline in HCV RNA levels 4 weeks after diagnosis of RAHCV infection was the strongest predictor of SC (P < .001; sensitivity, 96.4%; specificity, 97.5%; positive predictive value, 84.1%; negative predictive value, 99.5%). CONCLUSIONS: SC of RAHCV in HIV-positive MSM is found in only 11.9% of cases and a <2-log drop in HCV RNA level at week 4 after diagnosis should prompt early DAA-based treatment. However, immediate DAA treatment for RAHCV infection may also be favored in patients with ongoing transmission risk behavior.
引用
- Monin MB, Ingiliz P, Lutz T, et al. Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study). Clin Infect Dis. 2023. PMID: 36004410. doi:10.1093/cid/ciac680
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。